Health
NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells – News-Medical.Net
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and…
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
The findings were published today in Clinical Cancer Research, a journal of the American Association for Cancer Research. These results led to…
-
Business24 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News20 hours agoWilliam Robinson dies aged 89
-
Noosa News21 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats
-
Noosa News20 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89